EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway

Yuting Cheng, Guanjuan Liu, Xiaolin Huang, Yue Xiong, Na Song, Zheqing An, Wei Hong, Chidchanok Leethanakul, Bancha Samruajbenjakun iD, Jian Liao

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.70094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Yuting Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School/Hospital of Stomatology, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Zoledronic Acid, Autophagy, Lipopolysaccharides, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The present study was supported by the Natural Science Foundation of China (grant nos. 82260198 and 82060207), the Science and Technology Foundation of Guizhou….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammatory factors leading to bone loss significantly increase the risk of tooth loosening or implantation failure. Zoledronic acid (ZOL) is a widely used medication for effectively inhibiting excessive bone destruction, but its effect on alleviating inflammatory bone loss remains to be elucidated. In this study, we investigated whether ZOL alleviates inflammatory bone resorption through immunomodulatory effect.

Methods

The viability of the cells was evaluated by Cell Counting Kit 8 (CCK8) assay. Osteoclast (OC) differentiation and function were determined by tartrate‐resistant acid phosphatase (TRAP) staining and bone resorption pits assays, respectively. Autophagosomes and actin ring structures of OC were observed using transmission electron microscopy (TEM) and F‐actin ring staining, respectively. The microstructure in mice maxillary alveolar bone model was observed by micro computed tomography (Miro‐CT). Reverse transcription‐quantitative PCR (RT‐qPCR) to detect the mRNA expression of osteoclast‐related genes and Western blot (WB) analysis to evaluate the protein expression levels of autophagy‐related proteins and the NOD‐like receptor family pyrin domain‐containing protein 3 (NLRP3)‐related proteins in pre‐OCs.

Results

The findings indicated that ZOL hindered lipopolysaccharide (LPS)‐mediated OC differentiation, formation, bone resorption activity and autophagosome levels. Furthermore, ZOL diminished the expression of genes associated with OC. And the expression of proteins ATG7, LC3II, Beclin1, NLRP3‐related proteins and tumor necrosis factor‐α (TNF‐α) protein were markedly decreased while P62 was increased, especially in the 1 μM ZOL group or MCC950 + ZOL group.

Conclusions

ZOL has a certain immunomodulatory effect that exhibits anti‐inflammatory properties at lower concentrations, which can weaken LPS‐induced OCs differentiation and function, and NLRP3‐mediated autophagy pathway may participate in this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidAutophagyLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinOsteoclastsOsteogenesisMacrophagesAnimalsMiceCell DifferentiationMice, Inbred C57BLSignal TransductionBone ResorptionRAW 264.7 Cells

Stichwörter der Autor:innen

NLRP3autophagybone resorptionlipopolysaccharideosteoclastzoledronic acid

Substanzen

Zoledronic AcidLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouse

Autor:innen und Institutionen

  • School/Hospital of Stomatology, Guizhou Medical University, Guiyang, China.
  • Faculty of Dentistry, Prince of Songkla University, Hat Yai, Thailand.
  • Hospital of Stomatology, Zhongshan City, Zhongshan, China.
  • Key Laboratory of Endemic and Ethnic Diseases, Guizhou Medical University, Ministry of Education, Guiyang, China.

ORCID-Profile: Bancha Samruajbenjakun

Förderung

  • The present study was supported by the Natural Science Foundation of China (grant nos. 82260198 and 82060207), the Science and Technology Foundation of Guizhou…

Zitieren

APA

Cheng, Y., Liu, G., Huang, X., Xiong, Y., Song, N., An, Z., Hong, W., Leethanakul, C., Samruajbenjakun, B., & Liao, J. (2024). Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70094

Vancouver

Cheng Y, Liu G, Huang X, Xiong Y, Song N, An Z, et al. Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70094

BibTeX
@article{Cheng2024,
  author = {Cheng, Yuting and Liu, Guanjuan and Huang, Xiaolin and Xiong, Yue and Song, Na and An, Zheqing and Hong, Wei and Leethanakul, Chidchanok and Samruajbenjakun, Bancha and Liao, Jian},
  title = {Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.70094}
}
Kostenlos starten →